What is Needle-Free Drug Delivery Systems Market?
Needle-free drug delivery system is used to drive medicines using any force such as shock waves and pressure of gas through the skin. This process is done without a needle. The devices used for needle-free drug delivery are reusable. There is various type of needle-free drug delivery system such as Jet-based, spring-based and laser-based. Insulin delivery was the most protuberant application of needle-free drug delivery system.
The market study is being classified by Type (Jet-based, Spring-based and Laser-based), by Application (Pain management, Pediatric injections, Vaccine delivery, Oncology, Insulin delivery and Others) and major geographies with country level break-up. According to AMA, the Global Needle-Free Drug Delivery Systems market is expected to see growth rate of 12.5%
Antares Pharma (United States), Pharmajet (United States), Optinose (United States), Valeritas (United States), Crossject (France), Injex Pharma (Germany), 3M Pharmaceuticals (United States), Becton Dickinson (BD) (United States), MedImmune (United States), Mystic Pharmaceuticals (United States) and AkraDermojetInc (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Glide Pharmaceutical Technologies Ltd. (United Kingdom), Inovio Pharmaceuticals (United States) and Zogenix (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Needle-Free Drug Delivery Systems market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Needle-Free Drug Delivery Systems market by Type, Application and Region.
On the basis of geography, the market of Needle-Free Drug Delivery Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Fueling Demand of Pain free Delivery
- Increasing Demand of Self Administration of the Drug
Market Trend
- Rising Number of Infectious Diseases
- Introduction of Self-Inject able Drugs in Rheumatoid Arthritis
Restraints
- High Cost of Needle-Free Drug Delivery Systems
Opportunities
- Introduction of Technologically Advanced Products such as Insulin Micropump
Market Leaders and some development strategies
20th February 2018, PharmaJet announced that they have signed an agreement with South Korean biotherapeutics company Genexine to develop and commercialize DNA vaccines. From this deal, Genexine has gain access to use the PharmaJet Stratis as well as Tropis devices for their Phase I and Phase IIa human clinical studies.
25th July 2018, PharmaJet and Mundipharma are together for distribution of PharmaJet’s Tropics and Stratis needle-free drug-delivery devices. The devices used for vaccine immunizations.
Key Target Audience
Needle free drug delivery system Providers, Needle free drug delivery Devices Manufactures, Needle free drug delivery Devices Suppliers, Health Care Organizations, Re sellers, Potential Investors, Government and Private Research Organizations and Others
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase